[Skip to Content]
[Skip to Content Landing]
Article
January 1989

Results of Surgical Excision of One to 13 Hepatic Metastases in 98 Consecutive Patients

Author Affiliations

From the Department of Surgery, Ohio State University College of Medicine, Columbus.

Arch Surg. 1989;124(1):46-48. doi:10.1001/archsurg.1989.01410010052012
Abstract

• Metastatic carcinoma to the liver is generally considered to be associated with a poor prognosis, with five-year survival of only 20% to 30% after resection of solitary lesions. Ninety-eight consecutive patients underwent the surgical removal of one to 13 metastatic lesions from the liver. A rising carcinoembryonic antigen level was considered an indication for reexploration. All gross tumor was removed in every patient; 66 had more than one metastasis. Survival was unexpectedly high: 91 of 98 were alive at 12 months, 50 (70%) of 71 at 13 to 24 months, 23 (66%) of 36 at 25 to 36 months, 14 (74%) of 19 at 37 to 48 months, six (60%) of ten at 49 to 60 months, four (80%) of five at 61 to 72 months, and two (50%) of four 73 to 84 months after resection of multiple liver metastases. The procedure appears to be a safe and, in some patients, beneficial surgical technique for the removal of multiple hepatic metastases.

(Arch Surg 1989;124:46-48)

×